Abound Wealth Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36
Closed -$3.39K 1469
2026
Q1
$3.39K Hold
36
﹤0.01% 810
2025
Q4
$3.56K Hold
36
﹤0.01% 752
2025
Q3
$3.05K Hold
36
﹤0.01% 741
2025
Q2
$2.45K Hold
36
﹤0.01% 713
2025
Q1
$2.18K Sell
36
-16
-31% -$1.12K ﹤0.01% 686
2024
Q4
$3.59K Buy
52
+30
+136% +$2.14K ﹤0.01% 597
2024
Q3
$1.46K Hold
22
﹤0.01% 741
2024
Q2
$1.33K Hold
22
﹤0.01% 688
2024
Q1
$1.25K Hold
22
﹤0.01% 747
2023
Q4
$1.38K Hold
22
﹤0.01% 715
2023
Q3
$1.27K Sell
22
-10
-31% -$630 ﹤0.01% 680
2023
Q2
$1.99K Buy
32
+10
+45% +$668 ﹤0.01% 648
2023
Q1
$1.59K Hold
22
﹤0.01% 609
2022
Q4
$1.77K Hold
22
﹤0.01% 556
2022
Q3
$1.47K Buy
+22
New +$1.63K ﹤0.01% 535

Other funds holding INCY

Abound Wealth Management's INCY Position: Q2 2026 in Review

Abound Wealth Management sold out of Incyte (INCY) in Q2 2026, closing a stake of 36 shares — an estimated $3.39K sold.

Abound Wealth Management first reported a position in INCY in Q3 2022 and held it in 15 quarters. The position peaked at $3.59K in Q4 2024. 853 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Abound Wealth Management reported no remaining Incyte position as of Q2 2026 after selling out during the quarter.
  • Abound Wealth Management sold 36 Incyte shares in Q2 2026, an estimated $3.39K.
  • Abound Wealth Management first reported a position in Incyte in Q3 2022 and held it in 15 quarters.
  • Abound Wealth Management's Incyte position peaked at $3.59K in Q4 2024.
  • 853 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.